West Lafayette, IN, United States of America

Ekaterina Albert

USPTO Granted Patents = 22 (Patent Applications = 4)

CIPO Patents = 3

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 6.0

ph-index = 6

Forward Citations = 73(Granted Patents)

Location History:

Lafayette, IN (US) (2014 - 2015)
West Lafayette, IN (US) (2013 - 2024)

Company Filing History:

Biomed Valley Discoveries, Inc.

patents

4. 2 out of 43

Cymabay Therapeutics, Inc.

Albany Molecular Research, Inc.

patents

7. 1 out of 1

Mirati Therapepeutics, Inc.

Bial-portela Ca & S.a.

patents

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

22 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12297177 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2025-05-13),

2. 12116347 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2024-10-15),

3. 11905255 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2024-02-20),

4. 11884635 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2024-01-30),

5. 11884634 - Compositions of solid forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4- tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide (2024-01-30),

6. 11845732 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2023-12-19),

7. 11820748 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2023-11-21),

8. 11787819 - Crystalline salt of a multi-tyrosine kinase inhibitor, method of preparation, and use thereof (2023-10-17),

9. 11566006 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2023-01-31),

10. 10941118 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2021-03-09),

11. 10710966 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2020-07-14),

12. 10590087 - Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof (2020-03-17),

13. 9982007 - Cocrystals of progesterone (2018-05-29),

14. 9951041 - [object Object] (2018-04-24),

15. 9920045 - Solid state forms of a PDE10 inhibitor (2018-03-20),

Title: **Ekaterina Albert: An Innovative Contributor to Pharmaceutical Chemistry**

Introduction

Ekaterina Albert, based in West Lafayette, IN, has made significant strides in pharmaceutical chemistry. With a remarkable portfolio encompassing 21 patents, she has established herself as an influential figure in the field. Her latest innovations focus on solid-state forms of complex compounds aimed at treating tumors and cancers.

Latest Patents

Albert's latest patents include innovative solid-state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide. These patents reveal essential disclosures which relate to: a) solid-state forms of hydrobromide salts of Compound 1; b) pharmaceutical compositions comprising one or more solid-state forms of hydrobromide salts of Compound 1, and, optionally, a pharmaceutically acceptable carrier; c) methods of treating tumors or cancers by administering one or more solid-state forms of hydrobromide salts of Compound 1 to a subject in need thereof; and d) methods for the preparation of solid-state forms of Compound 1.

Career Highlights

Ekaterina Albert has an impressive career trajectory, having worked with prominent companies in the pharmaceutical sector such as Pfizer Corporation and Amri SSCI, LLC. Her experiences in these leading organizations have equipped her with invaluable skills in drug development and innovation.

Collaborations

Throughout her career, Albert has collaborated with esteemed colleagues including Elaine Greer and Stephen Anderson. These partnerships have enriched her research and contributed to her success in patenting groundbreaking inventions.

Conclusion

Ekaterina Albert stands out as a dedicated inventor in the pharmaceutical field. Her contributions not only advance scientific knowledge but also hold the potential to significantly impact cancer treatment methodologies. Through her innovative patents and collaborative efforts, she continues to inspire future generations of inventors and scientists.

This text is generated by artificial intelligence and may not be accurate.